IBDEI0JM ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26459,1,3,0)
 ;;=3^Trichiasis w/o Entropion
 ;;^UTILITY(U,$J,358.3,26459,1,4,0)
 ;;=4^374.05
 ;;^UTILITY(U,$J,358.3,26459,2)
 ;;=Trichiasis^269082
 ;;^UTILITY(U,$J,358.3,26460,0)
 ;;=375.21^^186^1699^69
 ;;^UTILITY(U,$J,358.3,26460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26460,1,3,0)
 ;;=3^Lacrimal,Epiphora,Excess
 ;;^UTILITY(U,$J,358.3,26460,1,4,0)
 ;;=4^375.21
 ;;^UTILITY(U,$J,358.3,26460,2)
 ;;=Epiphora, excess lacrimation^269137
 ;;^UTILITY(U,$J,358.3,26461,0)
 ;;=375.22^^186^1699^23
 ;;^UTILITY(U,$J,358.3,26461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26461,1,3,0)
 ;;=3^Epiphora, Insuff Drainage
 ;;^UTILITY(U,$J,358.3,26461,1,4,0)
 ;;=4^375.22
 ;;^UTILITY(U,$J,358.3,26461,2)
 ;;=Epiphora, Insuff Drainage^269138
 ;;^UTILITY(U,$J,358.3,26462,0)
 ;;=375.53^^186^1699^67
 ;;^UTILITY(U,$J,358.3,26462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26462,1,3,0)
 ;;=3^Lacrimal,Canal Stenosis
 ;;^UTILITY(U,$J,358.3,26462,1,4,0)
 ;;=4^375.53
 ;;^UTILITY(U,$J,358.3,26462,2)
 ;;=Lacrimal Canal Stenosis^269154
 ;;^UTILITY(U,$J,358.3,26463,0)
 ;;=375.51^^186^1699^70
 ;;^UTILITY(U,$J,358.3,26463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26463,1,3,0)
 ;;=3^Lacrimal,Punctum Eversion
 ;;^UTILITY(U,$J,358.3,26463,1,4,0)
 ;;=4^375.51
 ;;^UTILITY(U,$J,358.3,26463,2)
 ;;=Lacrimal Punctum Eversion^269150
 ;;^UTILITY(U,$J,358.3,26464,0)
 ;;=375.54^^186^1699^71
 ;;^UTILITY(U,$J,358.3,26464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26464,1,3,0)
 ;;=3^Lacrimal,Sac Stenosis
 ;;^UTILITY(U,$J,358.3,26464,1,4,0)
 ;;=4^375.54
 ;;^UTILITY(U,$J,358.3,26464,2)
 ;;=Lacrimal Punctum Stenosis^269156
 ;;^UTILITY(U,$J,358.3,26465,0)
 ;;=375.56^^186^1699^78
 ;;^UTILITY(U,$J,358.3,26465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26465,1,3,0)
 ;;=3^Nasolacrimal Duct Obstruction
 ;;^UTILITY(U,$J,358.3,26465,1,4,0)
 ;;=4^375.56
 ;;^UTILITY(U,$J,358.3,26465,2)
 ;;=Obstruction, Nasolacrimal duct^269159
 ;;^UTILITY(U,$J,358.3,26466,0)
 ;;=376.30^^186^1699^87
 ;;^UTILITY(U,$J,358.3,26466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26466,1,3,0)
 ;;=3^Orbit Exophalmos
 ;;^UTILITY(U,$J,358.3,26466,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,26466,2)
 ;;=Exophthalmos^43683
 ;;^UTILITY(U,$J,358.3,26467,0)
 ;;=802.8^^186^1699^88
 ;;^UTILITY(U,$J,358.3,26467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26467,1,3,0)
 ;;=3^Orbit Fracture
 ;;^UTILITY(U,$J,358.3,26467,1,4,0)
 ;;=4^802.8
 ;;^UTILITY(U,$J,358.3,26467,2)
 ;;=Fracture of Orbit^25315
 ;;^UTILITY(U,$J,358.3,26468,0)
 ;;=870.4^^186^1699^92
 ;;^UTILITY(U,$J,358.3,26468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26468,1,3,0)
 ;;=3^Orbit Penetrating Wound w/ Foreign Body
 ;;^UTILITY(U,$J,358.3,26468,1,4,0)
 ;;=4^870.4
 ;;^UTILITY(U,$J,358.3,26468,2)
 ;;=Foreign Body in Orbit^274883
 ;;^UTILITY(U,$J,358.3,26469,0)
 ;;=376.10^^186^1699^91
 ;;^UTILITY(U,$J,358.3,26469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26469,1,3,0)
 ;;=3^Orbit Inflammation,Chronic
 ;;^UTILITY(U,$J,358.3,26469,1,4,0)
 ;;=4^376.10
 ;;^UTILITY(U,$J,358.3,26469,2)
 ;;=Orbital Inflammation^269175
 ;;^UTILITY(U,$J,358.3,26470,0)
 ;;=360.41^^186^1699^66
 ;;^UTILITY(U,$J,358.3,26470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26470,1,3,0)
 ;;=3^Hypotensive Blind Phthisis,Blind
 ;;^UTILITY(U,$J,358.3,26470,1,4,0)
 ;;=4^360.41
 ;;^UTILITY(U,$J,358.3,26470,2)
 ;;=Phthisis^268564
 ;;^UTILITY(U,$J,358.3,26471,0)
 ;;=376.50^^186^1699^86
 ;;^UTILITY(U,$J,358.3,26471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26471,1,3,0)
 ;;=3^Orbit Enopthalmos
 ;;^UTILITY(U,$J,358.3,26471,1,4,0)
 ;;=4^376.50
 ;;^UTILITY(U,$J,358.3,26471,2)
 ;;=Enopthalmos^40801
 ;;^UTILITY(U,$J,358.3,26472,0)
 ;;=239.2^^186^1699^95
 ;;^UTILITY(U,$J,358.3,26472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26472,1,3,0)
 ;;=3^Orbital Tumor,Neopl,Unspec Nature
 ;;^UTILITY(U,$J,358.3,26472,1,4,0)
 ;;=4^239.2
 ;;^UTILITY(U,$J,358.3,26472,2)
 ;;=Orbital Tumor^267783
 ;;^UTILITY(U,$J,358.3,26473,0)
 ;;=239.7^^186^1699^79
 ;;^UTILITY(U,$J,358.3,26473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26473,1,3,0)
 ;;=3^Optic Nerve Neop,Unspec Nature
 ;;^UTILITY(U,$J,358.3,26473,1,4,0)
 ;;=4^239.7
 ;;^UTILITY(U,$J,358.3,26473,2)
 ;;=Optic Nerve Tumor^267785
 ;;^UTILITY(U,$J,358.3,26474,0)
 ;;=V52.2^^186^1699^2
 ;;^UTILITY(U,$J,358.3,26474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26474,1,3,0)
 ;;=3^Artificial Eye Prosthethic Check
 ;;^UTILITY(U,$J,358.3,26474,1,4,0)
 ;;=4^V52.2
 ;;^UTILITY(U,$J,358.3,26474,2)
 ;;=Prosthethic Eye Check^295498^V43.0
 ;;^UTILITY(U,$J,358.3,26475,0)
 ;;=173.10^^186^1699^56
 ;;^UTILITY(U,$J,358.3,26475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26475,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Unspec
 ;;^UTILITY(U,$J,358.3,26475,1,4,0)
 ;;=4^173.10
 ;;^UTILITY(U,$J,358.3,26475,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,26476,0)
 ;;=173.11^^186^1699^53
 ;;^UTILITY(U,$J,358.3,26476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26476,1,3,0)
 ;;=3^Eyelid/Canthus,BCC
 ;;^UTILITY(U,$J,358.3,26476,1,4,0)
 ;;=4^173.11
 ;;^UTILITY(U,$J,358.3,26476,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,26477,0)
 ;;=173.12^^186^1699^57
 ;;^UTILITY(U,$J,358.3,26477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26477,1,3,0)
 ;;=3^Eyelid/Canthus,SCC
 ;;^UTILITY(U,$J,358.3,26477,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,26477,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,26478,0)
 ;;=173.19^^186^1699^55
 ;;^UTILITY(U,$J,358.3,26478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26478,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Oth
 ;;^UTILITY(U,$J,358.3,26478,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,26478,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,26479,0)
 ;;=053.20^^186^1699^51
 ;;^UTILITY(U,$J,358.3,26479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26479,1,3,0)
 ;;=3^Eyelid,Herpes Zoster
 ;;^UTILITY(U,$J,358.3,26479,1,4,0)
 ;;=4^053.20
 ;;^UTILITY(U,$J,358.3,26479,2)
 ;;=^56937
 ;;^UTILITY(U,$J,358.3,26480,0)
 ;;=054.41^^186^1699^50
 ;;^UTILITY(U,$J,358.3,26480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26480,1,3,0)
 ;;=3^Eyelid,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,26480,1,4,0)
 ;;=4^054.41
 ;;^UTILITY(U,$J,358.3,26480,2)
 ;;=^266563
 ;;^UTILITY(U,$J,358.3,26481,0)
 ;;=078.0^^186^1699^77
 ;;^UTILITY(U,$J,358.3,26481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26481,1,3,0)
 ;;=3^Molluscum Contagiosum
 ;;^UTILITY(U,$J,358.3,26481,1,4,0)
 ;;=4^078.0
 ;;^UTILITY(U,$J,358.3,26481,2)
 ;;=^78675
 ;;^UTILITY(U,$J,358.3,26482,0)
 ;;=228.1^^186^1699^76
 ;;^UTILITY(U,$J,358.3,26482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26482,1,3,0)
 ;;=3^Lymphangioma
 ;;^UTILITY(U,$J,358.3,26482,1,4,0)
 ;;=4^228.1
 ;;^UTILITY(U,$J,358.3,26482,2)
 ;;=^72391
 ;;^UTILITY(U,$J,358.3,26483,0)
 ;;=238.2^^186^1699^3
 ;;^UTILITY(U,$J,358.3,26483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26483,1,3,0)
 ;;=3^Benign Neopl,Oth & Unspec Sites/Tissue
 ;;^UTILITY(U,$J,358.3,26483,1,4,0)
 ;;=4^238.2
 ;;^UTILITY(U,$J,358.3,26483,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,26484,0)
 ;;=242.00^^186^1699^61
 ;;^UTILITY(U,$J,358.3,26484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26484,1,3,0)
 ;;=3^Goiter Toxic Dif/Graves Thyrotoxic Exoph
 ;;^UTILITY(U,$J,358.3,26484,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,26484,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,26485,0)
 ;;=272.2^^186^1699^101
 ;;^UTILITY(U,$J,358.3,26485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26485,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,26485,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,26485,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,26486,0)
 ;;=360.40^^186^1699^60
 ;;^UTILITY(U,$J,358.3,26486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26486,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,26486,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,26486,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,26487,0)
 ;;=360.42^^186^1699^65
 ;;^UTILITY(U,$J,358.3,26487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26487,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,26487,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,26487,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,26488,0)
 ;;=360.89^^186^1699^59
 ;;^UTILITY(U,$J,358.3,26488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26488,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,26488,1,4,0)
 ;;=4^360.89
 ;;^UTILITY(U,$J,358.3,26488,2)
 ;;=^268581
 ;;^UTILITY(U,$J,358.3,26489,0)
 ;;=373.01^^186^1699^5
 ;;^UTILITY(U,$J,358.3,26489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26489,1,3,0)
 ;;=3^Blepharitis,Ulcerative
 ;;^UTILITY(U,$J,358.3,26489,1,4,0)
 ;;=4^373.01
 ;;^UTILITY(U,$J,358.3,26489,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,26490,0)
 ;;=373.31^^186^1699^49
 ;;^UTILITY(U,$J,358.3,26490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26490,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,26490,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,26490,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,26491,0)
 ;;=373.34^^186^1699^52
 ;;^UTILITY(U,$J,358.3,26491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26491,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,26491,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,26491,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,26492,0)
 ;;=373.9^^186^1699^37
 ;;^UTILITY(U,$J,358.3,26492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26492,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,26492,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,26492,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,26493,0)
 ;;=374.21^^186^1699^75
 ;;^UTILITY(U,$J,358.3,26493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26493,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,26493,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,26493,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,26494,0)
 ;;=374.22^^186^1699^74
 ;;^UTILITY(U,$J,358.3,26494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26494,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,26494,1,4,0)
 ;;=4^374.22
